Furthermore, the results of bioinformatics methods and dual-luciferase reporter assays showed that miR-103a mainly affected glucose metabolism and cell death by targeting ATP11A and EIF5 directly, thus contributing to HCC cell growth and mobility. Here, EIF5 is linked to hepatocellular carcinoma.